Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beth Baseler
Observed names:
B. Baseler,
Beth R Baseler,
Beth R. Baseler
Institutions:
Frederick National Laboratory for Cancer Research,
Leidos Biomedical Research Inc. (United States)
Observed institutions:
University of Sierra Leone,
Frederick National Laboratory for Cancer Research,
National Institute of Allergy and Infectious Diseases,
Leidos Biomedical Research Inc. (United States)
OpenAlex ID:
A5008746338
Works
15
Awards
17
Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease
2012
·
Lotty Ledwaba
, Jorge A. Tavel
, et al.
·
PLoS ONE
·
111
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022
·
ACTIV-3/TICO Study Group
, Angela J. Rogers
, et al.
·
Annals of Internal Medicine
·
61
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial
2022
·
ACTIV-3/TICO Study Group*
, Christina Barkauskas
, et al.
·
Annals of Internal Medicine
·
34
PDF
Beating the odds: Successful establishment of a Phase II/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak
2016
·
J. Doe-Anderson
, B. Baseler
, et al.
·
Contemporary Clinical Trials Communications
·
31
PDF
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases
2024
·
Aurélie Wiedemann
, Edouard Lhomme
, et al.
·
Nature Communications
·
29
PDF
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
2021
·
Moses Badio
, Edouard Lhomme
, et al.
·
Trials
·
25
PDF
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
2023
·
Andrew W Lee
, Ken Liu
, et al.
·
Clinical Infectious Diseases
·
22
PDF
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023
·
Samuel M Brown
, Christina E Barkauskas
, et al.
·
The Lancet Respiratory Medicine
·
21
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024
·
Neil R Aggarwal
, Jacquie Nordwall
, et al.
·
Clinical Infectious Diseases
·
19
PDF
Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency
2017
·
Gregg S. Larson
, Beth R. Baseler
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
17
PDF
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
2024
·
Simon Valayer
, Marie Alexandre
, et al.
·
Emerging Microbes & Infections
·
9
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
2024
·
Youyi Fong
, Lauren Dang
, et al.
·
Clinical Infectious Diseases
·
8
PDF
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023
·
Tomas O Jensen
, Greg A Grandits
, et al.
·
The Journal of Infectious Diseases
·
4
PDF
37 Supply and Logistics for Clinical Research in Low-Resource Settings
2024
·
Beth Baseler
, Calvin Proffitt
, et al.
·
Springer eBooks
·
1
PDF
42 Locally Hired Staff for Clinical Research Sites in Low-Resource Settings
2024
·
Beth Baseler
, Mary Smolskis
, et al.
·
Springer eBooks
PDF
Show more works
View as search
Works count:
15
Citation count:
392
H-index:
10
I10-index:
10
Year
Topic
Type